Subacute right ventricle perforation: a pacemaker lead complication.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
12 May 2021
Historique:
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 15 5 2021
Statut: epublish

Résumé

Myocardial perforation is an uncommon but potentially life-threatening complication of pacemaker and implantable cardioverter-defibrillator. Myocardial perforation may be acute, subacute or chronic when it occurs within 24 hours of the device insertion; between 1 day and 30 days; and more than 30 days after implantation. This complication may occur in 1.7%-7% of patients. However, subacute myocardial perforation is rare and affects 0.5%-1.2% of patients. We report the case of an 85-year-old patient with a pacemaker failure 10 days after implantation due to a subacute myocardial perforation caused by an active fixation ventricular lead. Transthoracic echocardiography showed penetration of the ventricular lead through the right ventricular apex into the pericardium without any pericardial effusion. We confirmed myocardial perforation by a CT scan. We referred her to the surgery ward where she was successfully managed.

Identifiants

pubmed: 33980566
pii: 14/5/e242489
doi: 10.1136/bcr-2021-242489
pmc: PMC8118073
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Pacing Clin Electrophysiol. 2014 Oct;37(10):1291-6
pubmed: 24888641
Europace. 2017 Jun 01;19(6):1031-1037
pubmed: 27353321
Heart Rhythm. 2005 Sep;2(9):907-11
pubmed: 16171740
Pacing Clin Electrophysiol. 2007 Jan;30(1):28-32
pubmed: 17241311
Pacing Clin Electrophysiol. 2014 May;37(5):537-45
pubmed: 24883448
Europace. 2017 Jan;19(1):96-102
pubmed: 26847075
Europace. 2009 Feb;11(2):206-12
pubmed: 19109359
Eur Radiol. 2019 Feb;29(2):963-974
pubmed: 30019144
J Cardiovasc Electrophysiol. 2014 Oct;25(10):1119-24
pubmed: 24863054
Am J Cardiol. 2008 Nov 15;102(10):1352-5
pubmed: 18993154

Auteurs

Emna Allouche (E)

Cardiology Department, Charles Nicolle Hospital, Tunis, Tunisia.
Faculty of Medecine, University of Tunis El Manar, Tunis, Tunisia.

Soumaya Chargui (S)

Internal Medicine, Charles Nicolle Hospital, Tunis, Tunisia chargui.souma@yahoo.fr.
Research Laboratory of Renal Pathology LR00SP01, Charles Nicolle Hospital, Tunis, Tunisia.

Marwa Fathi (M)

Cardiology Department, Charles Nicolle Hospital, Tunis, Tunisia.

Leila Bezdah (L)

Cardiology Department, Charles Nicolle Hospital, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH